Device Trial Radar · NCT02024880
Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer
Last checked: Nov 19, 2026Latest source record: Apr 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
600
Actual
Start
Jan 1, 2014
Primary completion
Nov 30, 2020
Study completion Nov 30, 2020
Sponsor
- Lead sponsor
- The University of Hong KongAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 31, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- Female only, up to 42 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In-vitro fertilization (IVF) treatment involves development of multiple follicles following ovarian stimulation, oocyte retrieval and embryo transfer (ET). ET is the final and most crucial step of IVF treatment. The ET catheter has to pass through the endocervical canal to go into the uterine cavity through the internal os. The endocervical canal may be filled up with mucus or blood. Embryos trapped in the mucus or blood after the passage of the endocervical canal may not be able to implant into the endometrium. Guardia™ Pro Protective ET catheter is designed to allow the safe passage of embryos through cervical mucus and blood as its outer sheath protects the embryo through entry and then opens in petals to further advance the inner catheter and gently place the embryo. The hypothesis of this study is that the pregnancy rate is significantly higher after ET using protective ET catheters.
Conditions
- Infertility
Interventions
Protective catheter groupDevice
The tip of this catheter is protected on insertion of the catheter.
Conventional catheter groupDevice
A standard embryo catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- ongoing pregnancy rateTime frame: 10 weeks of gestation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.